BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 593728)

  • 1. Uptake of [14C]oxamniquine by Schistosoma mansoni.
    Woolhouse NM; Kaye B
    Parasitology; 1977 Aug; 75(1):111-8. PubMed ID: 593728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of oxamniquine to the DNA of schistosomes.
    Pica-Mattoccia L; Cioli D; Archer S
    Trans R Soc Trop Med Hyg; 1989; 83(3):373-6. PubMed ID: 2617584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of Schistosoma mansoni prevalent in Saudi Arabia to oxamniquine in experimentally infected mice.
    Amin AM; Mikhail EG
    J Trop Med Hyg; 1988 Aug; 91(4):192-5. PubMed ID: 3136251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schistosoma mansoni: the survival and reproductive status of mature infections in mice treated with oxamniquine.
    Popiel I; Erasmus DA
    J Helminthol; 1982 Sep; 56(3):257-61. PubMed ID: 7175165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schistosoma mansoni: tegumental surface alterations following oxamniquine treatment of infected mice.
    Amin AM; Mikhail EG
    J Egypt Soc Parasitol; 1989 Dec; 19(2 Suppl):815-26. PubMed ID: 2507653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerance of Kenyan Schistosoma mansoni to oxamniquine.
    Coles GC; Mutahi WT; Kinoti GK; Bruce JI; Katz N
    Trans R Soc Trop Med Hyg; 1987; 81(5):782-5. PubMed ID: 3130689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schistosoma mansoni: ultrastructure of adults from mice treated with oxamniquine.
    Popiel I; Erasmus DA
    Exp Parasitol; 1984 Dec; 58(3):254-62. PubMed ID: 6499999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schistosoma mansoni: acquired immunity in mice after the use of oxamniquine at the evolutive skin and pulmonary phases.
    Coelho PM; Mello RT; Gerken SE
    Rev Inst Med Trop Sao Paulo; 1991; 33(1):28-31. PubMed ID: 1843393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmission and scanning electron microscopical studies in the tegument of male Schistosoma mansoni after oxamniquine treatment.
    Kohn A; López-Alvarez ML; Katz N
    Ann Parasitol Hum Comp; 1982; 57(3):285-91. PubMed ID: 7137803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of Schistosoma mansoni over a ten-hour period in vitro, and its modification by oxamniquine.
    Chavasse CJ; Brown MC; Bell DR
    Ann Trop Med Parasitol; 1979 Jun; 73(3):241-9. PubMed ID: 496475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schistosoma mansoni: structural damage after treatment with oxamniquine.
    Magalhães Filho A; de Melo ME; Padovan PA; Padovan IP
    Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():347-52. PubMed ID: 3509191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on some derivatives of oxamniquine.
    el-Hamouly W; Pica-Mattoccia L; Cioli D; Schwartz HM; Archer S
    J Med Chem; 1988 Aug; 31(8):1629-31. PubMed ID: 3398000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of oxamniquine praziquantel and clonazepam in experimental Schistosomiasis mansoni.
    Araujo N; Mattos AC; Coelho PM; Katz N
    Mem Inst Oswaldo Cruz; 2008 Dec; 103(8):781-5. PubMed ID: 19148417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of Schistosomiasis mansoni with a combination oxamniquine and praziquantel. II. Experimental observations during the patent phase].
    Campos R; Pinto PL; Amato Neto V; Moreira AA
    Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(3):111-4. PubMed ID: 2515575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the mode of action of oxamniquine and related schistosomicidal drugs.
    Pica-Mattoccia L; Cioli D
    Am J Trop Med Hyg; 1985 Jan; 34(1):112-8. PubMed ID: 3838223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversibility of drug-induced regression in female Schistosoma mansoni upon pairing with male worms in vivo.
    Popiel I; Cioli D; Erasmus DA
    Z Parasitenkd; 1984; 70(3):421-4. PubMed ID: 6741226
    [No Abstract]   [Full Text] [Related]  

  • 17. Short-term effects of oxamniquine on the activity in vitro of Schistosoma mansoni.
    Chavasse CJ; Brown MC; Bell DR
    Ann Trop Med Parasitol; 1978 Jun; 72(3):293-5. PubMed ID: 666401
    [No Abstract]   [Full Text] [Related]  

  • 18. Resistance to oxamniquine of a Schistosoma mansoni strain isolated from patient submitted to repeated treatments.
    Coelho PM; Lima e Silva FC; Nogueira-Machado JA
    Rev Inst Med Trop Sao Paulo; 1997; 39(2):101-6. PubMed ID: 9394523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzymatic basis for the lack of oxamniquine activity in Schistosoma haematobium infections.
    Pica-Mattoccia L; Novi A; Cioli D
    Parasitol Res; 1997; 83(7):687-9. PubMed ID: 9272559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ELISA detection of specific circulating antibodies against Schistosoma mansoni in mice after treatment with oxamniquine.
    Coelho PM; Tavares CA
    Braz J Med Biol Res; 1991; 24(5):485-93. PubMed ID: 1823263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.